Understanding the promising role of antibody drug conjugates in breast and ovarian cancer

Understanding the promising role of antibody drug conjugates in breast and ovarian cancer

A nascent category of anticancer therapeutic drugs called antibody-drug conjugates (ADCs) relate selectivity of aimed therapy using chemotherapeutic medicines with high cytotoxic power. Progressive linker technology led to the advancement of more efficacious and safer treatments. It offers neoteric...

Full description

Bibliographic Details
Main Authors: Ritchu Babbar, Vanya, Aarti Bassi, Rashmi Arora, Ankur Aggarwal, Pranay Wal, Sunil Kumar Dwivedi, Salma Alolayan, Monica Gulati, Celia Vargas-De-La-Cruz, Tapan Behl, Shreesh Ojha
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Heliyon
Subjects:
Antibody-drug conjugate
Breast cancer
Ovarian cancer
Payload
Cleavable linker
Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023086334

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023086334

Similar Items